A socioeconomic analysis of surgical treatment of migraine headaches

Plastic and Reconstructive Surgery

Volumn 129, Issue 4, 2012, Pages 871-877

  Faber, Carey ^a   Garcia, Ryan M ^a   Davis, Janine ^a   Guyuron, Bahman ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; COST; COST OF ILLNESS; DISABILITY; ECONOMICS; FEMALE; HUMAN; MALE; MIDDLE AGED; MIGRAINE; QUALITY OF LIFE; QUESTIONNAIRE; TRIGGER POINT; UNITED STATES;

ADULT; COST OF ILLNESS; COSTS AND COST ANALYSIS; DISABILITY EVALUATION; FEMALE; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; QUALITY OF LIFE; QUESTIONNAIRES; TRIGGER POINTS; UNITED STATES; YOUNG ADULT;

EID: 84859423618     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/PRS.0b013e318244217a     Document Type: Article

References (29)

1. Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M. Prevalenceand burden of migraine in the United States: Data from the American Migraine Study II. Headache 2001;41:646-657.
2. Lipton RB, Bigal ME, Diamond M, et al. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 2007;68:343-349.
3. Bigal ME, Lipton RB. The epidemiology, burden, and comorbidities of migraine. Neurol Clin. 2009;27:321-334.
4. Hazard E, Munakata J, Bigal ME, Rupnow MF, Lipton RB. The burden of migraine in the United States: Current and emerging perspectives on disease management and economic analysis. Value Health 2009;12:55-64.
5. Lipton RB, Bigal ME. Migraine: Epidemiology, impact, and risk factors for progression. Headache 2005;45(Suppl 1):S1-S13.
6. Goldberg LD. The cost of migraine and its treatment. Am J Manag Care 2005;11:S62-S67.
7. Hu XH, Markson LE, Lipton RB, Stewart WF, Berger ML. Burden of migraine in the United States: Disability and economic costs. Arch Intern Med. 1999;159:813-818.
8. Hawkins K, Wang S, Rupnow MF. Indirect cost burden of migraine in the United States. J Occup Environ Med. 2007; 49:368-374.
9. Guyuron B, Varghai A, Michelow BJ, Thomas T, Davis J. Corrugator supercilii muscle resection and migraine headaches. Plast Reconstr Surg. 2000;106:429-434; discussion 435-437.
10. Guyuron B, Tucker T, Davis J. Surgical treatment of migraine headaches. Plast Reconstr Surg. 2002;109:2183-2189.
11. Guyuron B, Kriegler JS, Davis J, Amini SB. Comprehensive surgical treatment of migraine headaches. Plast Reconstr Surg. 2005;115:1-9.
12. Guyuron B, Reed D, Kriegler JS, Davis J, Pashmini N, Amini S. A placebo-controlled surgical trial of the treatment of migraine headaches. Plast Reconstr Surg. 2009;124:461-468.
13. Dirnberger F, Becker K. Surgical treatment of migraine headaches by corrugator muscle resection. Plast Reconstr Surg. 2004;114:652-657; discussion 658-659.
14. Poggi JT, Grizzell BE, Helmer SD. Confirmation of surgical decompression to relieve migraine headaches. Plast Reconstr Surg. 2008;122:115-122; discussion 123-124.
15. Rapoport AM, Adelman JU. Cost of migraine management: apharmacoeconomic overview.Am J Manag Care;4:531-545.
16. Burton WN, Landy SH, Downs KE, Runken MC. The impact of migraine and the effect of migraine treatment on workplace productivity in the United States and suggestions for future research. Mayo Clin Proc. 2009;84:436-445.
17. Lofland JH, Kim SS, Batenhorst AS, et al. Cost-effectiveness and cost-benefit of sumatriptan in patients with migraine. Mayo Clin Proc. 2001;76:1093-1101.
18. Brown JS, Papadopoulos G, Neumann PJ, Friedman M, Miller JD, Menzin J. Cost-effectiveness of topiramate in migraine prevention: Results from a pharmacoeconomic model of topiramate treatment. Headache 2005;45:1012-1022.
19. Adelman JU, Von Seggern R. Cost considerations in headache treatment: Part 1. Prophylactic migraine treatment. Headache 1995;35:479-487.
20. GlaxoWellcome, Inc. MSQ Analyzer: A Data Entry and Scoring Tool for the Migraine Specific Quality-of-Life uestionnaire. Boston, Mass: Medical Outcomes Trust; 1999.
21. Stewart WF, Lipton RB, Kolodner K. Migraine Disability Assessment (MIDAS) score: Relation to headache frequency, painintensity, and headache symptoms. Headache 2003;43:258-265.
22. Barron R, Carlsen J, Duff SB, Burk C. Estimating the cost of an emergency room visit for migraine headaches. J Med Econ. 2003;6:43-53.
23. Pitts SR, Niska RW, Xu J, Burt CW. National Hospital Ambulatory Medical Care Survey: 2006 Emergency Department Summary. Natl Health Stat Rep. 2008;7:1-38.
24. Clouse JC, Osterhaus JT. Healthcare resource use and costs associated with migraine in a managed healthcare setting. Ann Pharmacother. 1994;28:659-676.
25. Hawkins K, Wang S, Rupnow M. Direct cost burden among insured S employees with migraine. Headache 2008;48:553-563.
26. Owens GM. Migraine in the managed care environment. Am J Manag Care 2005;11(Suppl):S68-S71.
27. Pesa J, Lage MJ. The medical cost of migraine and comorbid anxiety and depression. Headache 2004;44:562-570.
28. American Migraine Center. Personal communication, September 20, 2010.
29. Mitchell MP, Schaecher K, Cannon HE, Speckman M. Humanistic, utilization, and cost outcomes associated with the use of botulinum toxin for treatment of refractory migraine headaches in a managed care organization. J Manag Care Pharm. 2008;14:442-450.